A notable advancement in diabetes treatment is emerging with the approval of tirzepatide in a 45mg form. This new offering builds upon the existing success of tirzepatide, a dual GIP and GLP-1 receptor, and delivers a https://heidiuqdx325028.newsbloger.com/profile